< Back to all Breaking News
TENX
11/18/2016 08:11am
Tenax Therapeutics announces enrollment completion of phase 3 LEVO-CTS trial
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.